Related references
Note: Only part of the references are listed.Cytotoxic CD8+T cells in cancer and cancer immunotherapy
Hans Raskov et al.
BRITISH JOURNAL OF CANCER (2021)
Biodistribution and Pharmacokinectics of Liposomes and Exosomes in a Mouse Model of Sepsis
Amin Mirzaaghasi et al.
PHARMACEUTICS (2021)
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells
Kazushige Yoshida et al.
BMC CANCER (2020)
PD-1: A Driver or Passenger of T Cell Exhaustion?
Xing He et al.
MOLECULAR CELL (2020)
Melanoma Cancer Immunotherapy Using PD-L1 siRNA and Imatinib Promotes Cancer-Immunity Cycle
Chenyang Li et al.
PHARMACEUTICAL RESEARCH (2020)
The Role Of PD-1/PD-L1 Axis In Treg Development And Function: Implications For Cancer Immunotherapy
Jiajing Cai et al.
ONCOTARGETS AND THERAPY (2019)
Fates of CD8+ T cells in Tumor Microenvironment
Nomathamsanqa Resegofetse Maimela et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?
Markella Konstantinidou et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors
Jiemiao Hu et al.
CLINICAL CANCER RESEARCH (2018)
Immunotherapy for osteosarcoma: Where do we go from here?
Mary F. Wedekind et al.
PEDIATRIC BLOOD & CANCER (2018)
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
Jun Gong et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
B7-DC (PD-L2) costimulation of CD4+ T-helper 1 response via RGMb
Xinxin Nie et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2018)
Comparative Study of PEGylated and Conventional Liposomes as Carriers for Shikonin
Stella K. Tsermentseli et al.
FLUIDS (2018)
Proliferation of PD-1+CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients
Alice O. Kamphorst et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
PD-1 Blockade Promotes Emerging Checkpoint Inhibitors in Enhancing T Cell Responses to Allogeneic Dendritic Cells
Carmen Stecher et al.
FRONTIERS IN IMMUNOLOGY (2017)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential
Lucy M. De La Cruz et al.
IMMUNOTHERAPY (2016)
Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810
Gerald S. Falchook et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Phase I Study of Pembrolizumab (MK-3475; Anti-PD-1 Monoclonal Antibody) in Patients with Advanced Solid Tumors
Amita Patnaik et al.
CLINICAL CANCER RESEARCH (2015)
Advances and Challenges of Liposome Assisted Drug Delivery
Lisa Sercombe et al.
FRONTIERS IN PHARMACOLOGY (2015)
PDL1 expression is an independent prognostic factor in localized GIST
Francois Bertucci et al.
ONCOIMMUNOLOGY (2015)
PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy
Anne-Marit Sponaas et al.
PLOS ONE (2015)
Liposomal siRNA nanocarriers for cancer therapy
Bulent Ozpolat et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
Alena Gros et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells
Chen Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
A nanoformulation of siRNA and its role in cancer therapy: In vitro and in vivo evaluation
Hitesh Jagani et al.
CELLULAR & MOLECULAR BIOLOGY LETTERS (2013)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Current progress of siRNA/shRNA therapeutics in clinical trials
John C. Burnett et al.
BIOTECHNOLOGY JOURNAL (2011)
Imrnunostimulatory and antigen delivery properties of liposomes made up of total polar lipids from non-pathogenic bacteria leads to efficient induction of both innate and adaptive immune responses
Syed M. Faisal et al.
VACCINE (2011)
Lipid Vesicle Aggregation Induced by Cooling
Frank B. Howard et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2010)
Breaking down the barriers: siRNA delivery and endosome escape
Monika Dominska et al.
JOURNAL OF CELL SCIENCE (2010)
Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells
Takashi Inozume et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Delivering nanomedicine to solid tumors
Rakesh K. Jain et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Doxorubicin enhances CD4+ T-cell immune responses by inducing expression of CD40 ligand and 4-1BB
Jae Yeo Park et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion
Christian Blank et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma
Padmanee Sharma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Tumor infiltrating FOXP3+ regulatory T-cells are associated with recurrence in pathologic stage INSCLC patients
Rebecca P. Petersen et al.
CANCER (2006)
Enhancing siRNA effects in T cells for adoptive immunotherapy
K Morris et al.
HEMATOLOGY (2005)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Expression of ST2 in helper T lymphocytes of malignant pleural effusions
K Oshikawa et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
An analysis of cytokine status in the serum and effusions of patients with tuberculous and lung cancer
YM Chen et al.
LUNG CANCER (2001)
Share Paper
